<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Guex, Anne Géraldine</dc:creator>
  <dc:creator>Frobert, A.</dc:creator>
  <dc:creator>Valentin, Jeremy</dc:creator>
  <dc:creator>Fortunato, G.</dc:creator>
  <dc:creator>Hegemann, D.</dc:creator>
  <dc:creator>Cook, Stéphane</dc:creator>
  <dc:creator>Carrel, Thierry P.</dc:creator>
  <dc:creator>Tevaearai, H.T.</dc:creator>
  <dc:creator>Giraud, Marie-Noëlle</dc:creator>
  <dc:date>2014-02-14</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Cardiac tissue engineering approaches can deliver large numbers of cells to the damaged myocardium and have thus increasingly been considered as a possible curative treatment to counteract the high prevalence of progressive heart failure after myocardial infarction (MI). Optimal scaffold architecture and mechanical and chemical properties, as well as immune- and bio-compatibility, need to be addressed. We demonstrated that radio-frequency plasma surface functionalized electrospun poly(ɛ-caprolactone) (PCL) fibres provide a suitable matrix for bone-marrow-derived mesenchymal stem cell (MSC) cardiac implantation. Using a rat model of chronic MI, we showed that MSC-seeded plasma-coated PCL grafts stabilized cardiac function and attenuated dilatation. Significant relative decreases of 13% of the ejection fraction (EF) and 15% of the fractional shortening (FS) were observed in sham treated animals; respective decreases of 20% and 25% were measured 4 weeks after acellular patch implantation, whereas a steadied function was observed 4 weeks after MSC-patch implantation (relative decreases of 6% for both EF and FS).</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/303542</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/303542/files/coo_pfe.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/303542/files/coo_pfe_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.actbio.2014.01.006</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Acta Biomaterialia. - 2014, vol. 10, no. 7, p. 2996–3006</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Cardiac tissue engineering</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">In vivo functional evaluation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Electrospinning</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Plasma polymerization</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Echocardiography cell therapy</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns6="xml" ns6:lang="en">Plasma-functionalized electrospun matrix for biograft development and cardiac function stabilization</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
